Chicago, IL, United States of America

Javier Izquierdo-Ferrer

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Javier Izquierdo-Ferrer

Introduction

Javier Izquierdo-Ferrer is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of therapeutics, particularly in the development of compounds that target cancer-related pathways. With a total of 4 patents to his name, his work is paving the way for new treatment options.

Latest Patents

One of his latest patents is titled "Substituted heterocycles as c-MYC targeting agents." This patent discloses substituted heterocycle compounds, including substituted pyrazoles, substituted pyrimidines, and substituted triazoles. These compounds have shown promise in inhibiting c-MYC, a protein that plays a crucial role in cancer progression. The potential therapeutic applications of these compounds could significantly impact the treatment of cancer and cell proliferative disorders.

Career Highlights

Javier Izquierdo-Ferrer is affiliated with Northwestern University, where he conducts his research and development work. His innovative approach to drug design and his focus on targeting specific cancer pathways have established him as a key figure in his field. His contributions are not only advancing scientific knowledge but also offering hope for new cancer therapies.

Collaborations

Javier has collaborated with esteemed colleagues such as Gary E Schiltz and Rama K Mishra. These partnerships enhance the research efforts and broaden the scope of innovation within their projects.

Conclusion

Javier Izquierdo-Ferrer is a prominent inventor whose work in developing c-MYC targeting agents is making strides in cancer therapeutics. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…